135 related articles for article (PubMed ID: 2511700)
1. [Development and status of nitrate therapy in East Germany].
Engelmann L; Wetzler G; Kucher A; Frömmel H
Z Kardiol; 1989; 78 Suppl 2():99-101; discussion 115-7. PubMed ID: 2511700
[TBL] [Abstract][Full Text] [Related]
2. [Long-term effect of various nitrates in ischemic heart disease and latent heart failure].
Assmann I; Dueck KD
Z Kardiol; 1989; 78 Suppl 2():68-71; discussion 115-7. PubMed ID: 2511696
[TBL] [Abstract][Full Text] [Related]
3. Effects of expiring reimbursability of pentaerythrityl tetranitrate (PETN, pentalong®) on anti-anginal therapy: an observational study.
Grimmsmann T; Chenot JF; Angelow A
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):803-11. PubMed ID: 26043680
[TBL] [Abstract][Full Text] [Related]
4. Potency and in vitro tolerance of organic nitrates: partially denitrated metabolites contribute to the tolerance-devoid activity of pentaerythrityl tetranitrate.
Koenig A; Lange K; Konter J; Daiber A; Stalleicken D; Glusa E; Lehmann J
J Cardiovasc Pharmacol; 2007 Jul; 50(1):68-74. PubMed ID: 17666918
[TBL] [Abstract][Full Text] [Related]
5. Rapid microbial degradation of organic nitrates in rat excreta. Re-examination of the urinary and fecal metabolite profiles of pentaerythritol tetranitrate in the rat.
King SY; Fung HL
Drug Metab Dispos; 1984; 12(3):353-7. PubMed ID: 6145563
[TBL] [Abstract][Full Text] [Related]
6. [Long-term nitrate therapy in coronary heart disease--loss of effect by developing tolerance].
Dück KD; Richard F
Z Gesamte Inn Med; 1990 Dec; 45(24):736-41. PubMed ID: 2129317
[TBL] [Abstract][Full Text] [Related]
7. [The hemodynamic profile of pentaerythrityl tetranitrate].
Engelmann L; Gottschild D
Z Gesamte Inn Med; 1981 Apr; 36(7):244-6. PubMed ID: 7281826
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of pentaerythritol tetranitrate in two doses in patients with stable angina pectoris].
Kośmicki MA; Malczewska B; Sadowski Z
Przegl Lek; 2005; 62(1):8-12. PubMed ID: 16053212
[TBL] [Abstract][Full Text] [Related]
9. [Therapy with NO donors-antiatherogenic and antioxidant actions].
Grosser N; Schröder H
Herz; 2004 Feb; 29(1):116-22. PubMed ID: 14968347
[TBL] [Abstract][Full Text] [Related]
10. Sustained hemodynamic and antianginal effects of high dose oral isosorbide dinitrate.
Aronow S
Nouv Presse Med; 1980 Sep; 9(34 Suppl):2483-6. PubMed ID: 7422537
[TBL] [Abstract][Full Text] [Related]
11. [Avoidance of tolerance development to long term therapy with nitrates through correct dosage].
Blasini R; Reiniger G; Rudolph W
Z Kardiol; 1986; 75 Suppl 3():42-9. PubMed ID: 3541418
[TBL] [Abstract][Full Text] [Related]
12. Is the use of long acting nitrates beneficial in the patient with angina pectoris? (The negative side).
Goldstein RE
Cardiovasc Clin; 1977; 8(1):149-58. PubMed ID: 403005
[No Abstract] [Full Text] [Related]
13. [Dose-response relationship of nitrate therapy of angina pectoris].
Schneider W; Kaltenbach M
Z Kardiol; 1986; 75 Suppl 3():61-7. PubMed ID: 3099486
[TBL] [Abstract][Full Text] [Related]
14. [Special place of PETN among nitrates. No tolerance development, fewer headaches].
Münzel T
MMW Fortschr Med; 2008 Jan; 150(1-2):41. PubMed ID: 18300643
[No Abstract] [Full Text] [Related]
15. Cost comparison analysis: pentaerythrithyl tetranitrate (PETN) and isosorbide dinitrate (ISDN) prescribed to diabetic patients in primary care practices in Germany.
Icks A; Haastert B; Rathmann W; Schröder-Bernhardi D; Giani G
Int J Clin Pharmacol Ther; 2007 Sep; 45(9):516-23. PubMed ID: 17907594
[TBL] [Abstract][Full Text] [Related]
16. Comparison of glyceryl trinitrate-induced with pentaerythrityl tetranitrate-induced in vivo formation of superoxide radicals: effect of vitamin C.
Dikalov S; Fink B; Skatchkov M; Bassenge E
Free Radic Biol Med; 1999 Jul; 27(1-2):170-6. PubMed ID: 10443933
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of three oral nitrate derivatives. A hemodynamic assessment in 10 patients with chronic heart failure (author's transl)].
Bory M; Clavier P; Arnoux F; Djiane P; Egre A; Serradimigni A
Nouv Presse Med; 1980 Sep; 9(34 Suppl):2437-42. PubMed ID: 6775296
[TBL] [Abstract][Full Text] [Related]
18. What intervals in oral therapy of isosorbide dinitrate in various doses are sufficient to prevent nitrate tolerance?
Kośmicki M; Sadowski Z; Szwed H; Kowalik I
Med Sci Monit; 2000; 6(4):763-8. PubMed ID: 11208406
[TBL] [Abstract][Full Text] [Related]
19. [Are nitrate compounds effective when administered orally? Results of pharmacokinetic and hemodynamic studies].
Baligadoo S; Chiche P
Nouv Presse Med; 1980 Sep; 9(34 Suppl):2419-23. PubMed ID: 6775293
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates.
Daiber A; Oelze M; Coldewey M; Bachschmid M; Wenzel P; Sydow K; Wendt M; Kleschyov AL; Stalleicken D; Ullrich V; Mülsch A; Münzel T
Mol Pharmacol; 2004 Dec; 66(6):1372-82. PubMed ID: 15331769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
